Literature DB >> 10856250

Separate domains in E1 and E2 proteins serve architectural and productive roles for cooperative DNA binding.

E Gillitzer1, G Chen, A Stenlund.   

Abstract

The E1 and E2 proteins from bovine papillomavirus bind cooperatively to binding sites in the viral origin of DNA replication. The DNA-binding domains (DBDs) of the two proteins interact with each other, and the E2 transactivation domain interacts with the helicase domain of E1. Mutations that disrupt the interaction between the two DBDs also disrupt the interaction between the E2 activation domain and the E1 helicase domain, demonstrating interdependence of the two interactions. Cooperative binding of the two DBDs generates a sharp bend in the DNA that is required for interaction between the E2 activation domain and E1. This indicates that interaction between the two DBDs plays an architectural role, 'triggering' a productive interaction between the E2 transactivation domain and E1 through introduction of a sharp bend in the DNA. This two-step mechanism may be a required feature for cooperative DNA binding to proximal binding sites.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10856250      PMCID: PMC203343          DOI: 10.1093/emboj/19.12.3069

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

1.  Crystal structure at 1.7 A of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target.

Authors:  R S Hegde; S R Grossman; L A Laimins; P B Sigler
Journal:  Nature       Date:  1992-10-08       Impact factor: 49.962

2.  Formation of the complex of bovine papillomavirus E1 and E2 proteins is modulated by E2 phosphorylation and depends upon sequences within the carboxyl terminus of E1.

Authors:  M Lusky; E Fontane
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

Review 3.  HMG domain proteins: architectural elements in the assembly of nucleoprotein structures.

Authors:  R Grosschedl; K Giese; J Pagel
Journal:  Trends Genet       Date:  1994-03       Impact factor: 11.639

4.  The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator.

Authors:  E Ustav; M Ustav; P Szymanski; A Stenlund
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

5.  DNA bending and orientation-dependent function of YY1 in the c-fos promoter.

Authors:  S Natesan; M Z Gilman
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

6.  Crystal structure of LacI member, PurR, bound to DNA: minor groove binding by alpha helices.

Authors:  M A Schumacher; K Y Choi; H Zalkin; R G Brennan
Journal:  Science       Date:  1994-11-04       Impact factor: 47.728

7.  Cooperative assembly of the bovine papilloma virus E1 and E2 proteins on the replication origin requires an intact E2 binding site.

Authors:  M Lusky; J Hurwitz; Y S Seo
Journal:  J Biol Chem       Date:  1993-07-25       Impact factor: 5.157

8.  Bovine papilloma virus (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication.

Authors:  Y S Seo; F Müller; M Lusky; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

9.  Yeast a1 and alpha 2 homeodomain proteins form a DNA-binding activity with properties distinct from those of either protein.

Authors:  C Goutte; A D Johnson
Journal:  J Mol Biol       Date:  1993-10-05       Impact factor: 5.469

10.  DNase I-induced DNA conformation. 2 A structure of a DNase I-octamer complex.

Authors:  A Lahm; D Suck
Journal:  J Mol Biol       Date:  1991-12-05       Impact factor: 5.469

View more
  24 in total

1.  The E1 initiator recognizes multiple overlapping sites in the papillomavirus origin of DNA replication.

Authors:  G Chen; A Stenlund
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Crystal structures of two intermediates in the assembly of the papillomavirus replication initiation complex.

Authors:  Eric J Enemark; Arne Stenlund; Leemor Joshua-Tor
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

3.  Sequential and ordered assembly of E1 initiator complexes on the papillomavirus origin of DNA replication generates progressive structural changes related to melting.

Authors:  Grace Chen; Arne Stenlund
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

4.  Using competition assays to quantitatively model cooperative binding by transcription factors and other ligands.

Authors:  Jacob Peacock; James B Jaynes
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-01       Impact factor: 3.770

5.  E1 initiator DNA binding specificity is unmasked by selective inhibition of non-specific DNA binding.

Authors:  Arne Stenlund
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

6.  Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300.

Authors:  Andreas Müller; Andreas Ritzkowsky; Gertrud Steger
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

7.  The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2.

Authors:  Eric A Abbate; James M Berger; Michael R Botchan
Journal:  Genes Dev       Date:  2004-08-02       Impact factor: 11.361

8.  Direct interaction between nucleosome assembly protein 1 and the papillomavirus E2 proteins involved in activation of transcription.

Authors:  Manuela Rehtanz; Hanns-Martin Schmidt; Ursula Warthorst; Gertrud Steger
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

9.  NFI and Oct-1 bend the Ad5 origin in the same direction leading to optimal DNA replication.

Authors:  Monika E Mysiak; Claire Wyman; P Elly Holthuizen; Peter C van der Vliet
Journal:  Nucleic Acids Res       Date:  2004-12-01       Impact factor: 16.971

10.  Replication from oriP of Epstein-Barr virus requires exact spacing of two bound dimers of EBNA1 which bend DNA.

Authors:  J M Bashaw; J L Yates
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.